Nebenwirkungen · Roclanda
Roclanda 50 micrograms/ml + 200 micrograms/ml eye drops, solution · Abschnitt 4.8 · PDF-Seite 5
HOS-144341 · Präparat HOS-099162
The following adverse reactions have been reported with latanoprost + netarsudil, dosed once daily, and during clinical studies and post-marketing surveillance with the individual components latanoprost and netarsudil. Adverse reactions are presented according to the MedDRA system organ classification. Within each system organ class, the adverse reactions are classified by frequency according to the following convention: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1 000 to <1/100), rare (≥1/10 000 to <1/1 000), very rare (<1/10 000) or not known (cannot be estimated from the available data).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-12T11:25:00Z · SHA-256 87849a8418cacd034df5be09c055fa9f8742a5f7b9c507d3191aa1e9899e02d9 · Passage 831573877558f4822c00aae14eb849390d3fc445e2d7db91bb1778821d158ffd · Zeichen 314–928 im Abschnitt